Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

PR Permian Resources Corporation
$21.43 1.11% +0.23
Notify me if price changes either direction
Interactive Brokers Logotype

Buy PR stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

Permian Resources Corporation (PR)

Loading

Key Stats

Market cap. 17.8B
Enterprise value 20.9B
Trailing PE 10.979275
Forward PE 7.53768
PEG Ratio 0.050673576923077
Enterprise to EBITDA 4.749
Enterprise to revenue 3.282
Price to book MRQ 1.4435588
Price to sales TTM 2.7886207

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 6.4B
EBITDA 4.6B
Diluted EPS TTM 1.93
Total Cash (MRQ) 95.0M
Current ratio (MRQ) 0.498
Operating Cash Flow (TTM) 4.5B

PR trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months
Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.